FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199382643> ?p ?o ?g. }

• W3199382643 endingPage "106121" @default.
• W3199382643 startingPage "106121" @default.
• W3199382643 abstract "There is little information regarding the safety of intravenous tissue plasminogen activator (IV-tPA) in patients with stroke and COVID-19.This multicenter study included consecutive stroke patients with and without COVID-19 treated with IV-tPA between February 18, 2019, to December 31, 2020, at 9 centers participating in the CASCADE initiative. Clinical outcomes included modified Rankin Scale (mRS) at hospital discharge, in-hospital mortality, the rate of hemorrhagic transformation. Using Bayesian multiple regression and after adjusting for variables with significant value in univariable analysis, we reported the posterior adjusted odds ratio (OR, with 95% Credible Intervals [CrI]) of the main outcomes.A total of 545 stroke patients, including 101 patients with COVID-19 were evaluated. Patients with COVID-19 had a more severe stroke at admission. In the study cohort, 85 (15.9%) patients had a hemorrhagic transformation, and 72 (13.1%) died in the hospital. After adjustment for confounding variables, discharge mRS score ≥2 (OR: 0.73, 95% CrI: 0.16, 3.05), in-hospital mortality (OR: 2.06, 95% CrI: 0.76, 5.53), and hemorrhagic transformation (OR: 1.514, 95% CrI: 0.66, 3.31) were similar in COVID-19 and non COVID-19 patients. High-sensitivity C reactive protein level was a predictor of hemorrhagic transformation in all cases (OR:1.01, 95%CI: 1.0026, 1.018), including those with COVID-19 (OR:1.024, 95%CI:1.002, 1.054).IV-tPA treatment in patients with acute ischemic stroke and COVID-19 was not associated with an increased risk of disability, mortality, and hemorrhagic transformation compared to those without COVID-19. IV-tPA should continue to be considered as the standard of care in patients with hyper acute stroke and COVID-19." @default.
• W3199382643 created "2021-09-27" @default.
• W3199382643 creator A5001908694 @default.
• W3199382643 creator A5005332761 @default.
• W3199382643 creator A5006048595 @default.
• W3199382643 creator A5006968849 @default.
• W3199382643 creator A5008495581 @default.
• W3199382643 creator A5009797115 @default.
• W3199382643 creator A5010662353 @default.
• W3199382643 creator A5011857498 @default.
• W3199382643 creator A5012965660 @default.
• W3199382643 creator A5015743063 @default.
• W3199382643 creator A5016503923 @default.
• W3199382643 creator A5018598096 @default.
• W3199382643 creator A5018605276 @default.
• W3199382643 creator A5022276754 @default.
• W3199382643 creator A5022823811 @default.
• W3199382643 creator A5024985035 @default.
• W3199382643 creator A5025072857 @default.
• W3199382643 creator A5028145030 @default.
• W3199382643 creator A5028822431 @default.
• W3199382643 creator A5029647514 @default.
• W3199382643 creator A5030365497 @default.
• W3199382643 creator A5032353664 @default.
• W3199382643 creator A5035747864 @default.
• W3199382643 creator A5037430368 @default.
• W3199382643 creator A5038050829 @default.
• W3199382643 creator A5041058276 @default.
• W3199382643 creator A5043300449 @default.
• W3199382643 creator A5044156349 @default.
• W3199382643 creator A5044994081 @default.
• W3199382643 creator A5048221888 @default.
• W3199382643 creator A5050507154 @default.
• W3199382643 creator A5052837170 @default.
• W3199382643 creator A5054146130 @default.
• W3199382643 creator A5054681519 @default.
• W3199382643 creator A5054892108 @default.
• W3199382643 creator A5056042858 @default.
• W3199382643 creator A5056794015 @default.
• W3199382643 creator A5061812764 @default.
• W3199382643 creator A5063014062 @default.
• W3199382643 creator A5064346735 @default.
• W3199382643 creator A5065727519 @default.
• W3199382643 creator A5074277589 @default.
• W3199382643 creator A5075369472 @default.
• W3199382643 creator A5079618352 @default.
• W3199382643 creator A5080408998 @default.
• W3199382643 creator A5083544354 @default.
• W3199382643 creator A5084773338 @default.
• W3199382643 creator A5084908935 @default.
• W3199382643 creator A5086169818 @default.
• W3199382643 creator A5087515424 @default.
• W3199382643 creator A5087849908 @default.
• W3199382643 creator A5087951596 @default.
• W3199382643 creator A5088364999 @default.
• W3199382643 creator A5088450432 @default.
• W3199382643 creator A5089540833 @default.
• W3199382643 creator A5089618661 @default.
• W3199382643 date "2021-12-01" @default.
• W3199382643 modified "2023-10-13" @default.
• W3199382643 title "Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative" @default.
• W3199382643 cites W2050798863 @default.
• W3199382643 cites W2067395123 @default.
• W3199382643 cites W2102447759 @default.
• W3199382643 cites W2138595885 @default.
• W3199382643 cites W2142727778 @default.
• W3199382643 cites W2159233098 @default.
• W3199382643 cites W2203714058 @default.
• W3199382643 cites W2939177772 @default.
• W3199382643 cites W3013310257 @default.
• W3199382643 cites W3016319555 @default.
• W3199382643 cites W3023141957 @default.
• W3199382643 cites W3023179304 @default.
• W3199382643 cites W3028162226 @default.
• W3199382643 cites W3032383509 @default.
• W3199382643 cites W3037564140 @default.
• W3199382643 cites W3039107853 @default.
• W3199382643 cites W3039555118 @default.
• W3199382643 cites W3044976402 @default.
• W3199382643 cites W3047476427 @default.
• W3199382643 cites W3049378851 @default.
• W3199382643 cites W3088465282 @default.
• W3199382643 cites W3093968859 @default.
• W3199382643 cites W3095909202 @default.
• W3199382643 cites W3097214010 @default.
• W3199382643 cites W3123389740 @default.
• W3199382643 cites W3124312192 @default.
• W3199382643 cites W3133769718 @default.
• W3199382643 cites W3136012160 @default.
• W3199382643 cites W3138475122 @default.
• W3199382643 cites W3161773261 @default.
• W3199382643 cites W4206310953 @default.
• W3199382643 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106121" @default.
• W3199382643 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8450304" @default.
• W3199382643 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34601242" @default.
• W3199382643 hasPublicationYear "2021" @default.
• W3199382643 type Work @default.
• W3199382643 sameAs 3199382643 @default.

• next